Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

• Status: Withdrawn
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to validate the Japanese electronic florbetapir (18F) interpretation training program intended for post-approval implementation in Japan.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Avid Radiopharmaceuticals

Criteria

Inclusion Criteria:

• Japanese Society of Nuclear Medicine (JSNM) Positron Emission Tomography (PET) Certified Nuclear Medicine Physician

• Minimal hands-on experience and no formal training in the visual interpretation of florbetapir (18F) brain PET scans

• Minimal hands-on experience and no formal training in the quantitation of florbetapir (18F) brain PET scans

Exclusion Criteria:

• Prior hands-on experience or formal training in the visual interpretation and/or quantitation of florbetapir (18F) PET scans